Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The association of endocannabinoid receptor genes (CNR1 and CNR2) polymorphisms with depression
Xiangjuan Kong, Qingshan Miao, Xiaozi Lu, et al.
Medicine (2019) Vol. 98, Iss. 46, pp. e17403-e17403
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Biological, Psychological, and Social Determinants of Depression: A Review of Recent Literature
Olivia Remes, João Francisco Mendes, Peter Templeton
Brain Sciences (2021) Vol. 11, Iss. 12, pp. 1633-1633
Open Access | Times Cited: 238
Astrocytic cannabinoid receptor 1 promotes resilience by dampening stress-induced blood–brain barrier alterations
Katarzyna Dudek, Sam E.J. Paton, Luisa Bandeira Binder, et al.
Nature Neuroscience (2025)
Open Access | Times Cited: 4
A comprehensive review of the multifaceted role of cannabinoid receptor type 2 in neurodegenerative and neuropsychiatric disorders
María S. García‐Gutiérrez, Abraham B. Torregrosa, Francisco Navarrete, et al.
Pharmacological Research (2025) Vol. 213, pp. 107657-107657
Open Access | Times Cited: 3
Endocannabinoid System Components as Potential Biomarkers in Psychiatry
Francisco Navarrete, María S. García‐Gutiérrez, Rosa Jurado‐Barba, et al.
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 106
Neurobiology of cannabinoid receptor signaling
Beat Lutz
Dialogues in Clinical Neuroscience (2020) Vol. 22, Iss. 3, pp. 207-222
Open Access | Times Cited: 82
Microglial Inflammatory-Metabolic Pathways and Their Potential Therapeutic Implication in Major Depressive Disorder
Reza Rahimian, Claudia Belliveau, Rebecca Chen, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 48
Inflammation and Nitro-oxidative Stress as Drivers of Endocannabinoid System Aberrations in Mood Disorders and Schizophrenia
Gerwyn Morris, Luba Sominsky, Kenneth R. Walder, et al.
Molecular Neurobiology (2022) Vol. 59, Iss. 6, pp. 3485-3503
Closed Access | Times Cited: 30
Modulation of Endocannabinoid System Components in Depression: Pre-Clinical and Clinical Evidence
Uri Bright, Irit Akirav
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 10, pp. 5526-5526
Open Access | Times Cited: 30
Cannabis Pharmacogenomics: A Path to Personalized Medicine
Mariana Babayeva, Zvi G. Loewy
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 4, pp. 3479-3514
Open Access | Times Cited: 18
Psychiatric Comorbidities of Inflammatory Bowel Disease: It Is a Matter of Microglia’s Gut Feeling
Gohar Fakhfouri, Nataša R. Mijailović, Reza Rahimian
Cells (2024) Vol. 13, Iss. 2, pp. 177-177
Open Access | Times Cited: 7
Meet Your Stress Management Professionals: The Endocannabinoids
Terri A. deRoon‐Cassini, Todd M. Stollenwerk, Margaret Beatka, et al.
Trends in Molecular Medicine (2020) Vol. 26, Iss. 10, pp. 953-968
Open Access | Times Cited: 49
The endocannabinoidome in neuropsychiatry: Opportunities and potential risks
Gerwyn Morris, Ken Walder, Stefan Kloiber, et al.
Pharmacological Research (2021) Vol. 170, pp. 105729-105729
Closed Access | Times Cited: 33
Molecular Alterations of the Endocannabinoid System in Psychiatric Disorders
Daniela Navarro, Ani Gasparyan, Francisco Navarrete, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 4764-4764
Open Access | Times Cited: 26
Can Physical Activity Support the Endocannabinoid System in the Preventive and Therapeutic Approach to Neurological Disorders?
Tomasz Charytoniuk, Hubert Żywno, Karolina Konstantynowicz-Nowicka, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 12, pp. 4221-4221
Open Access | Times Cited: 28
Cannabinoids and their therapeutic applications in mental disorders
María Scherma, Anna Lisa Muntoni, Gernot Riedel, et al.
Dialogues in Clinical Neuroscience (2020) Vol. 22, Iss. 3, pp. 271-279
Open Access | Times Cited: 27
G protein-coupled receptor (GPCR) pharmacogenomics
Miles D. Thompson, David Reiner‐Link, Alessandro Berghella, et al.
Critical Reviews in Clinical Laboratory Sciences (2024) Vol. 61, Iss. 8, pp. 641-684
Open Access | Times Cited: 3
Genetic Insights into the Molecular Pathophysiology of Depression in Parkinson’s Disease
Efthalia Angelopoulou, Anastasia Bougea, Yam Nath Paudel, et al.
Medicina (2023) Vol. 59, Iss. 6, pp. 1138-1138
Open Access | Times Cited: 8
On the Role of Central Type-1 Cannabinoid Receptor Gene Regulation in Food Intake and Eating Behaviors
Mariangela Pucci, Elizabeta Zaplatić, Maria Vittoria Micioni Di Bonaventura, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 1, pp. 398-398
Open Access | Times Cited: 18
Variability in cannabinoid receptor genes is associated with psychiatric comorbidities in anorexia nervosa
Luz María González, Angustias García‐Herráiz, Sonia Mota-Zamorano, et al.
Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity (2021) Vol. 26, Iss. 8, pp. 2597-2606
Closed Access | Times Cited: 17
Genetic variation of the 5‐HT1A rs6295, 5‐HT2A rs6311, and CNR1 rs1049353 and an altered endocannabinoid system in depressed patients
Jasmin Obermanns, H. Meiser, S.M. Hoberg, et al.
Brain and Behavior (2023) Vol. 13, Iss. 12
Open Access | Times Cited: 6
Resilience to fear: The role of individual factors in amygdala response to stressors
Rosalina Fonseca, Natália Madeira, Carla Simões
Molecular and Cellular Neuroscience (2020) Vol. 110, pp. 103582-103582
Closed Access | Times Cited: 11
Correlations of the CNR1 Gene with Personality Traits in Women with Alcohol Use Disorder
Filip Maciocha, Aleksandra Suchanecka, Krzysztof Chmielowiec, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5174-5174
Open Access | Times Cited: 1
Cannabinoids: Role in Neurological Diseases and Psychiatric Disorders
Ujendra Kumar
International Journal of Molecular Sciences (2024) Vol. 26, Iss. 1, pp. 152-152
Open Access | Times Cited: 1
Endocannabinoid system in the neurodevelopment of GABAergic interneurons: implications for neurological and psychiatric disorders
Changgeng Song, Xin Kang, Fang Yang, et al.
Reviews in the Neurosciences (2021) Vol. 32, Iss. 8, pp. 803-831
Open Access | Times Cited: 8
Genetic variations in the retrograde endocannabinoid signaling pathway in Chinese patients with major depressive disorder
Huifang Xu, Tongtong Li, Qiyong Gong, et al.
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top